Histogen Stock Price, News & Analysis
Company Description
Histogen (OTC: HSTO) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
HSTO stock has declined 33.9% over the past year. Shares last traded at $0.2100.
This page provides a comprehensive overview of HSTO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Histogen (HSTO) stock last traded at $0.2100. Over the past 12 months, the stock has lost 33.9%.
Latest News
Histogen has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings. View all HSTO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HSTO Company Profile & Sector Positioning
Histogen (HSTO) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.